HCV Elimination Program in Rwanda (National program)
Virus targets
Hepatitis B
Hepatitis C
Type
Testing and treatment implementation
Setting
National
Phase
Active
Health outcomes
Incidence
Mortality
Prevalence
WHO region
African Region
Country
Rwanda
Key interventions
Community mobilization
Hepatitis B Vaccination
Prevention mother-child transmission
Screening and diagnosis
Strategic data analysis
Treatment (direct or referral)
Target population
Adults
Household contact(s)
Newborn (born in last 30 days)
Occupations with possible exposure
Pregnant women
Performance target
Care cascade: Evidence of current infection
Care cascade: HBV diagnosis
Care cascade: HBV testing
Care cascade: HBV treatment
Care cascade: HCV diagnosis
Care cascade: HCV testing
Care cascade: HCV treatment
Care cascade: Referred for treatment
HBV prevention of mother to child transmission
Vaccination coverage
Health outcomes additional info
- By 2024: Screen 4,000,000 people for HCV, 90% of the population 15 years and older and also treat 110,000, 80% of those diagnosed positive for HCV
- Decrease prevalence of HCV and HBV from 4% to 1.2% by 2024
- Decrease liver cancer rate from 8% to less than 1%
Performance target additional info
Rwanda's target is to scale up viral hepatitis elimination implementation by 2024 rather than 2030
Summary and objectives
In less than 5 years Rwanda plans to :
- Screen for HCV 4 Millions people aged 15 and above
- 110,000 would have cured (90% of targeted pop)
- Reduce HCV prevalence from an estimate of 4% to 1.2%
- Average patients cured per year: 22,400
- Reduce liver cancers from 8% to <1 %
Read more about the program here
